These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 11401083)
21. Comparison of the effects of fibrinogen and fibrin products and isolated peptide chains on the fibrin-mediated stimulation of plasminogen activation by tissue-type plasminogen activator, and on the fibrin-dependent enhancement of the amidolytic activity of one-chain tissue-type plasminogen activator. Fischer B Biol Chem Hoppe Seyler; 1990 Nov; 371(11):1067-75. PubMed ID: 2128181 [TBL] [Abstract][Full Text] [Related]
22. [Plasminogen activation by a tissue activator and effector properties of fibrinogen-N-terminal disulfide (N-DSK) fibrin complex]. Makogonenko EM; Druzhina NN; Lugovskoĭ EV; Kolesnik LA; Kudinov SA Ukr Biokhim Zh (1978); 1991; 63(3):17-23. PubMed ID: 1926582 [TBL] [Abstract][Full Text] [Related]
23. Functional properties of a recombinant chimeric protein with combined thrombin inhibitory and plasminogen-activating potential. Lijnen HR; Wnendt S; Schneider J; Janocha E; Van Hoef B; Collen D; Steffens GJ Eur J Biochem; 1995 Nov; 234(1):350-7. PubMed ID: 8529664 [TBL] [Abstract][Full Text] [Related]
24. Effect of oxidized fibrinogen on aggregation of activated platelets and neutrophils. Aseychev AV; Azizova OA; Shulenina LV; Piryazev AP Bull Exp Biol Med; 2009 Mar; 147(3):312-8. PubMed ID: 19529851 [TBL] [Abstract][Full Text] [Related]
25. A comparative study of amyloid-beta (1-42) as a cofactor for plasminogen activation by vampire bat plasminogen activator and recombinant human tissue-type plasminogen activator. Kruithof EK; Schleuning WD Thromb Haemost; 2004 Sep; 92(3):559-67. PubMed ID: 15351852 [TBL] [Abstract][Full Text] [Related]
26. Fibrinogenolysis and thrombin generation after reduced dose bolus or conventional rt-PA for pulmonary embolism. The Coagulation Project Investigators of the Bolus Alteplase Pulmonary Embolism Group. Agnelli G; Iorio A; Parise P; Goldhaber SZ; Levine MN Blood Coagul Fibrinolysis; 1997 Jun; 8(4):216-22. PubMed ID: 9199818 [TBL] [Abstract][Full Text] [Related]
27. Investigation of residues in the fibrin(ogen) gamma chain involved in tissue plasminogen activator binding and plasminogen activation. Wilhelm SE; Lounes KC; Lord ST Blood Coagul Fibrinolysis; 2004 Sep; 15(6):451-61. PubMed ID: 15311153 [TBL] [Abstract][Full Text] [Related]
28. Effects of intact fibrin and partially plasmin-degraded fibrin on kinetic properties of one-chain tissue-type plasminogen activator. Fischer BE; Will H Biochim Biophys Acta; 1990 Oct; 1041(1):48-54. PubMed ID: 2145980 [TBL] [Abstract][Full Text] [Related]
29. The fibrinogen antigenic turbidimetric assay (FIATA): the X2x test--the corrected chi-square comparison against the control-mean. Stief TW Clin Appl Thromb Hemost; 2007 Jan; 13(1):73-100. PubMed ID: 17164498 [TBL] [Abstract][Full Text] [Related]
35. Differences between neonates and adults in tissue-type-plasminogen activator (t-PA)-catalyzed plasminogen activation with various effectors and in carbohydrate sequences of fibrinogen chains. Ries M; Easton RL; Longstaff C; Zenker M; Corran PH; Morris HR; Dell A; Gaffney PJ Thromb Res; 2001 Aug; 103(3):173-84. PubMed ID: 11672579 [TBL] [Abstract][Full Text] [Related]
36. Thrombin treated plasma employed as a standard for determination of soluble fibrin. Halvorsen S; Skjønsberg OH; Godal HC Thromb Res; 1993 Nov; 72(4):305-13. PubMed ID: 8303670 [TBL] [Abstract][Full Text] [Related]
37. The composition of complexes between plasminogen activator inhibitor 1, vitronectin and either thrombin or tissue-type plasminogen activator. van Meijer M; Stoop A; Smilde A; Preissner KT; van Zonneveld AJ; Pannekoek H Thromb Haemost; 1997 Mar; 77(3):516-21. PubMed ID: 9066004 [TBL] [Abstract][Full Text] [Related]
38. A simple rapid method for isolating soluble fibrin complexes from fibrinogen by treatment with thrombin and t-AMCHA. Hayashi S; Yamada K Thromb Haemost; 1980 Feb; 42(5):1388-97. PubMed ID: 6154323 [TBL] [Abstract][Full Text] [Related]
39. The relative kinetics of clotting and lysis provide a biochemical rationale for the correlation between elevated fibrinogen and cardiovascular disease. Kim PY; Stewart RJ; Lipson SM; Nesheim ME J Thromb Haemost; 2007 Jun; 5(6):1250-6. PubMed ID: 17266698 [TBL] [Abstract][Full Text] [Related]